Consensus Hologic, Inc.

Equities

HOLX

US4364401012

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 20/09/2024 BST			5-day change	1st Jan Change
81.39 ^USD	-1.23%		+1.21%	+13.91%

09-13	Hologic Board Approves $1.5 Billion Share Buyback Plan	MT
09-13	Hologic, Inc. announces an Equity Buyback for $1,500 million worth of its shares.	CI

Evolution of the Average Target: Hologic, Inc.

Evolution of the Target Price: Hologic, Inc.

Changes in Analyst Recommendations: Hologic, Inc.

cb91ccc1e173c5d9cba5107752e4.Gyf-PyXS146Blfgd_1EuZeXOhAdD_2w0iy7t9jkc9Fg.ekvKZ1eolNG5oa0ljTd2DK-B4T8auCFC2mOgvwAvxC1TUatLTYqgttjMtQ~feaec6a7ff0f4fe90bcaaef3b4d519a6

Analysts' recommendations: Hologic, Inc.

RBC Raises Price Target on Hologic to $86 From $82, Keeps Sector Perform Rating	09-13	MT
Nephron Trims Price Target on Hologic to $92 From $95	09-11	MT
Stephens Raises Hologic's Price Target to $95 From $92	08-02	MT
BNP Paribas Exane Adjusts Price Target on Hologic to $96 From $95	07-31	MT
UBS Adjusts Hologic Price Target to $84 From $81, Maintains Neutral Rating	07-30	MT
Evercore ISI Adjusts Hologic Price Target to $78 From $76	07-30	MT
JPMorgan Adjusts Hologic Price Target to $95 From $91	07-30	MT
Raymond James Adjusts Hologic Price Target to $93 From $88	07-30	MT
RBC Raises Price Target on Hologic to $82 From $81, Keeps Sector Perform Rating	07-30	MT
Stephens Adjusts Price Target on Hologic to $92 From $87	07-22	MT
Leerink Partners Adjusts Price Target on Hologic to $95 From $90	07-18	MT
Evercore ISI Adjusts Price Target on Hologic to $76 From $78, Maintains In-line Rating	07-02	MT
Stephens Initiates Coverage on Hologic With Overweight Rating, $87 Price Target	06-27	MT
Argus Adjusts Price Target on Hologic to $95 From $89	05-09	MT
JPMorgan Adjusts Price Target on Hologic to $91 From $85	05-03	MT
UBS Adjusts Price Target on Hologic to $81 From $79, Maintains Neutral Rating	05-03	MT
RBC Raises Price Target on Hologic to $81 From $76, Keeps Sector Perform Rating	04-08	MT
Citigroup Upgrades Hologic to Buy From Neutral, Raises Price Target to $95 From $80	04-03	MT
UBS Adjusts Hologic's Price Target to $79 From $78, Maintains Neutral Rating	02-02	MT
Needham Adjusts Price Target on Hologic to $90 From $83, Maintains Buy Rating	02-02	MT
BofA Securities Raises Price Target on Hologic to $80 From $75, Maintains Neutral Rating	01-29	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	01-03
UBS Cuts Price Target on Hologic to $78 From $91, Maintains Neutral Rating	11-16	MT
Morgan Stanley Cuts Price Target on Hologic to $82 From $86, Keeps Equalweight Rating	11-13	MT
Analyst recommendations: Airbnb, Apple, Best Buy, Diageo, Tesla...	11-13

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	HOLOGIC, INC.					+5.99%
	THERMO FISHER SCIENTIFIC INC.					+3.73%
	DANAHER CORPORATION					+4.20%
	INTUITIVE SURGICAL, INC.					-1.24%
	BOSTON SCIENTIFIC CORPORATION					+4.24%
	SIEMENS HEALTHINEERS AG					+19.25%
	GE HEALTHCARE TECHNOLOGIES INC.					+5.08%
	AGILENT TECHNOLOGIES, INC.					+3.92%
	EDWARDS LIFESCIENCES CORPORATION					+17.25%
	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.					+58.65%
	Average					+12.11%
	Weighted average by Cap.					+6.88%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

81.39USD

Average target price

87.33USD

Spread / Average Target

+7.30%

High Price Target

96.00USD

Spread / Highest target

+17.95%

Low Price Target

70.00USD

Spread / Lowest Target

-13.99%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
Nephron Research
Argus
JPMorgan Chase
UBS
Citigroup
Needham & Co.
BofA Securities
Morgan Stanley
Raymond James
Mizuho Securities
Wells Fargo Securities
Baptista Research
Cowen
SVB Securities LLC
Evercore ISI
BTIG
Redburn
Jefferies & Co.